Citius Oncology Inc.

XNAS:CTOR   1:33:57 PM EDT
0.59
-0.04 (-5.64%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)52.09M
Current PEN/A
Forward PE N/A
2yr Forward PE 1.51
See more stats
Estimates Current Quarter
Revenue$7 Million
Adjusted EPS-$0.01
See more estimates
10-Day MA$0.74
50-Day MA$1.03
200-Day MA$1.62
See more pivots

Citius Oncology Inc. Stock, XNAS:CTOR

11 Commerce Drive, 1st floor, Cranford, New Jersey 07016
United States of America
Phone:
Number of Employees:

Description

Citius Oncology, Inc. is a pharmaceutical company, which engages in developing and commercializing targeted oncology therapies. Its lead product candidate is LYMPHIR, an engineered IL-2 diphtheria toxin fusion protein, for the treatment of patients with persistent or recurrent CTCL, a rare form of non-Hodgkin lymphoma. The company was founded on March 1, 2021 and is headquartered in Cranford, NJ.